SCHEMBL8947940

SCHEMBL8947940

O=C(O)c1ccccc1-c1c2ccc(=O)cc-2oc2ccccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 4/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
MEN1 O00255 5/20 0.53
KMT2A Q03164 5/20 0.53
POLB P06746 3/20 0.53
ATM Q13315 1/20 0.53
PLEC Q15149 1/20 0.53
KDM4E B2RXH2 4/20 0.52
FTO Q9C0B1 2/20 0.51
ALPL P05186 1/20 0.50
ALPI P09923 1/20 0.50
ALPG P10696 1/20 0.50
SOS1 Q07889 2/20 0.48
DNASE1L3 Q13609 1/20 0.47
PRMT1 Q99873 1/20 0.47
CYP3A4 P08684 3/20 0.45
HPGD P15428 3/20 0.45
MAPT P10636 2/20 0.45
ALOX15 P16050 2/20 0.45
RECQL P46063 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12238062 0.89 USP2 (0.57) USP2L3MBTL1MEN1KMT2APOLB
SCHEMBL29781098 0.88 USP2 (0.76) USP2L3MBTL1MEN1KMT2APOLB
SCHEMBL107875 0.88 USP2 (0.76) USP2L3MBTL1MEN1KMT2APOLB
SCHEMBL29591827 0.88 USP2 (0.76) USP2L3MBTL1MEN1KMT2APOLB
SCHEMBL3430200 0.87 USP2 (0.74) USP2L3MBTL1MEN1KMT2APOLB
SCHEMBL7591292 0.87 USP2 (0.74) USP2L3MBTL1MEN1KMT2APOLB
SCHEMBL8451224 0.87 USP2 (0.74) USP2L3MBTL1MEN1KMT2APOLB
SCHEMBL10060277 0.87 POLB (0.59) USP2L3MBTL1MEN1KMT2APOLB
SCHEMBL16232679 0.86 ABCB1 (0.58) USP2L3MBTL1MEN1KMT2APOLB
SCHEMBL14847588 0.85 USP2 (0.56) USP2L3MBTL1MEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11666428-B2 Straw for the preservation of a predetermined dose of liquid-based substance, in particular pure or diluted animal semen; and set comprising it IMV TECHNOLOGIES (FR) 2023-06-06 US disclosed
US-20180092723-A1 Straw for the preservation of a predetermined dose of liquid-based substance IMV TECHNOLOGIES (FR) 2018-04-05 US disclosed
US-9688743-B2 Optical biosensors CARNEGIE MELLON UNIVERSITY (US) 2017-06-27 US disclosed
US-9676948-B2 Coating composition and method for determining the uniformity and thickness of a no-rinse silane pretreatment MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2017-06-13 US disclosed
US-20170065390-A1 Straw for the preservation of a predetermined dose of liquid-based substance, in particular a biological substance IMV TECHNOLOGIES (FR) 2017-03-09 US disclosed
US-20170045484-A1 AMINO ACID-BASED COMPOUND FOR DETECTING CARBON DIOXIDE, CARBON DIOXIDE CHEMICAL SENSOR AND CARBON DIOXIDE DETECTION METHOD USING THE SAME GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2017-02-16 US disclosed
US-20170042145-A1 Hydrotesting and Mothballing Composition and Method of using Combination Products for Multifunctional Water Treatment CLARIANT INTERNATIONAL, LTD. (CH) 2017-02-16 US disclosed
US-9504637-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2016-11-29 US disclosed
US-20160278905-A1 Straw for the preservation of a predetermined dose of liquid-based substance, in particular pure or diluted animal semen; and set comprising it IMV TECHNOLOGIES (FR) 2016-09-29 US disclosed
US-20160237177-A1 SINGLE-STEP FUNCTIONALIZATION AND CROSS-LINKING OF HYALURONIC ACID GALDERMA S.A. (CH) 2016-08-18 US disclosed
US-20150174026-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. 2015-06-25 US disclosed
US-8932370-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2015-01-13 US disclosed
US-20140342164-A1 COATING COMPOSITION AND METHOD FOR DETERMINING THE UNIFORMITY AND THICKNESS OF A NO-RINSE SILANE PRETREATMENT MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2014-11-20 US disclosed
US-20140326269-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. 2014-11-06 US disclosed
US-8758451-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2014-06-24 US disclosed
US-20140013520-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. 2014-01-16 US disclosed
US-8444715-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2013-05-21 US disclosed
US-20120272990-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. (US) 2012-11-01 US disclosed
US-8187340-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2012-05-29 US disclosed
US-20110154583-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. (US) 2011-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120272990-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 USP2 2643/4885L3MBTL1 3693/4885MEN1 3187/4885
US-20170042145-A1 Hydrotesting and Mothballing Composition and Method of using Combination Products for Multifunctional Water Treatment DNMT3A, ACIN1, SRM USP2 3443/4885L3MBTL1 620/4885MEN1 3638/4885
US-20160237177-A1 SINGLE-STEP FUNCTIONALIZATION AND CROSS-LINKING OF HYALURONIC ACID CD44, HAO2, HAO1 USP2 724/4885L3MBTL1 4748/4885MEN1 4131/4885
US-20110154583-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 USP2 2643/4885L3MBTL1 3693/4885MEN1 3187/4885
US-20170065390-A1 Straw for the preservation of a predetermined dose of liquid-based substance, in particular a biological substance CSTB, MASP2, SPPL2B USP2 146/4885L3MBTL1 121/4885MEN1 3984/4885
US-20140013520-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 USP2 2643/4885L3MBTL1 3693/4885MEN1 3187/4885
US-20160278905-A1 Straw for the preservation of a predetermined dose of liquid-based substance, in particular pure or diluted animal semen; and set comprising it ZP1, ACR, PIGS USP2 1855/4885L3MBTL1 913/4885MEN1 3421/4885
US-20150174026-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 USP2 2643/4885L3MBTL1 3693/4885MEN1 3187/4885
US-11666428-B2 Straw for the preservation of a predetermined dose of liquid-based substance, in particular pure or diluted animal semen; and set comprising it ZP1, ACR, PIGS USP2 1855/4885L3MBTL1 913/4885MEN1 3421/4885
US-20140326269-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 USP2 2643/4885L3MBTL1 3693/4885MEN1 3187/4885
US-20170045484-A1 AMINO ACID-BASED COMPOUND FOR DETECTING CARBON DIOXIDE, CARBON DIOXIDE CHEMICAL SENSOR AND CARBON DIOXIDE DETECTION METHOD USING THE SAME DAO, BCAT1, BCAT2 USP2 1882/4885L3MBTL1 996/4885MEN1 3592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.